Article

John Botson, MD: Challenges Associated With Treating Gout

Gout must be treated every day rather than as a single event.

John Botson, MD

John Botson, MD

As new guidelines for gout are published, many challenges still exist in treating the condition.

John Botson, MD, a clinical rheumatologist in Anchorage, Alaska, told HCPLive® the biggest challenge with gout is the way the condition is being looked at. He said primary care providers are very familiar with gout because patients will come in with a swollen toe and they cannot work and are miserable. When the attack goes away, they still have the uric acid crystals in their joints and bodies.

“But they don’t think about it anymore,” Botson said.

Providers need to be aware of this and refer the patient to a rheumatologist. A big challenge is identifying the patients who are going to podiatry offices or with a primary care provider and never present to a rheumatologist because they don’t think about the need to go to 1 or because they don’t have enough episodes.

“That’s the challenge,” he said. “Getting the word out that this is something we have to treat every day—preventatively almost—instead of just waiting for a bad episode to happen.”

To learn more about the challenges of gout, watch the video featuring Botson below.

Related Videos
Orrin Troum, MD: Accurately Imaging Gout With DECT Scanning
John Stone, MD, MPH: Continuing Progress With IgG4-Related Disease Research
Philip Conaghan, MBBS, PhD: Investigating NT3 Inhibition for Improving Osteoarthritis
Rheumatologists Recognize the Need to Create Pediatric Enthesitis Scoring Tool
Presence of Diffuse Cutaneous Disease Linked to Worse HRQOL in Systematic Sclerosis
Alexei Grom, MD: Exploring Safer Treatment Options for Refractory Macrophage Activation Syndrome
Jack Arnold, MBBS, clinical research fellow, University of Leeds, Leeds Institute of Rheumatic and Musculoskeletal Medicine
John Tesser, MD, Adjunct Assistant Professor of Medicine, Midwestern University, and Arizona College of Osteopathic Medicine, and Lecturer, University of Arizona Health Sciences Center, and Arizona Arthritis & Rheumatology Associates
Gaith Noaiseh, MD: Nipocalimab Improves Disease Measures, Reduces Autoantibodies in Sjogren’s
Laure Gossec, MD, PhD: Informing Physician Treatment Choices for Psoriatic Arthritis
© 2024 MJH Life Sciences

All rights reserved.